Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session
Today, 7:56 AM
Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022
Today, 7:56 AM
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…
EF Hutton Initiates Coverage On Coeptis Therapeutics with Buy Rating, Announces Price Target of $6
Today, 7:56 AM
EF Hutton analyst Michael King initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and announces Price Target of $6.
Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Today, 7:56 AM
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
EF Hutton Initiates Coverage On Coeptis Therapeutics with Buy Rating, Announces Price Target of $6
Today, 7:56 AM
EF Hutton analyst Michael King initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and announces Price Target of $6.
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Session
Today, 7:56 AM
Gainers
Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Today, 7:56 AM
Gainers Autolus Therapeutics (NASDAQ:AUTL) stock moved upwards by 15.0% to $2.3 during Tuesday’s after-market session. The market value…
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Today, 7:56 AM
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Coeptis Therapeutics Intends To Acquire Statera’s TLR5 Agonist Platform
Today, 7:56 AM
Coeptis Therapeutics Inc (OTC:COEP) has entered into a strategic agreement with Statera Biopharma Inc (NASDAQ:STAB) that gives Coeptis the right to acquire Statera’stoll-like…